Digest Network Come funziona
Network
/
Società
Ta
Non verificato

Takeda Pharmaceutical Company Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

59 comunicati stampa

Guarda tutti i comunicati
09/09/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
28/08/2026
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
24/08/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
05/08/2026
Industria
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
30/07/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Titoli e azioni
Eventi
Oncologia
Salute
Igiene alimentare
Farmaceutica
Biotecnologia
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
16/07/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
12/07/2026
Mercato del lavoro
Industria
Medicina - Varie
Attrezzature medico-sanitarie
Sanità
Management
Biotecnologia
Salute
Farmaceutica
Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
24/06/2026
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Oncologia
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
15/06/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0
11/06/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Fonte
Takeda Pharmaceutical Company Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0